EGFR overexpression
Clinical trials for EGFR overexpression explained in plain language.
Never miss a new study
Get alerted when new EGFR overexpression trials appear
Sign up with your email to follow new studies for EGFR overexpression, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a vaccine teach the immune system to fight HER2-Positive tumors?
Disease control Recruiting nowThis phase 1 trial tests a vaccine made from two HER2 protein fragments in people with advanced breast or esophageal cancers that have spread or cannot be removed. The vaccine aims to train the immune system to recognize and attack HER2-positive tumor cells. Participants receive …
Matched conditions: EGFR OVEREXPRESSION
Phase 1 • Sponsor: Pravin T.P Kaumaya • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug YH32364 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis study tests an experimental drug called YH32364 in adults with advanced solid tumors that have high levels of EGFR and have not responded to previous treatments. The trial has two parts: first, finding a safe dose in about 30 people, then testing that dose in 50 people with …
Matched conditions: EGFR OVEREXPRESSION
Phase 1/2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC